Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.

Hepatic stellate cells (HSCs) activation leads to major fibrogenic response in liver fibrosis. Selective localization of drug to HSCs can provide effective antifibrotic therapy. Thus, objectives of study were to prepare peroxisome proliferator-activated receptor-γ ligand (rosiglitazone) loaded mannose 6-phosphate modified human serum albumin (M6P-HSA) conjugated liposomes and evaluate pharmacokinetically and pharmacodynamically in rats for application of findings of studies in development of suitable and relevant product for treatment of liver fibrosis. The HSA was derivatized with mannose 6-phosphate and then coupled to optimized liposomes. Drug distribution in liver and other tissues after intravenous administration in carbon tetrachloride-induced liver fibrosis model rats was studied. Histopathological examination, estimation of biochemical markers, and grading of liver fibrosis was performed to evaluate pharmacodynamic efficacy of prepared formulation. The M6P-HSA conjugation to liposomes enhanced rosiglitazone liver uptake significantly (2.61 folds) and disappeared from systemic circulation at double rate. Favorable pharmacokinetics resulted in improved histopathological morphology, biochemical markers level, and decreased fibrosis grade. Hence, critical scrutiny of results suggested preferential and enhanced drug localization in pathogenic cells of liver providing a thinking which may result in development of product that can provide cure or at least prevention to this progressive disease necessitating liver transplant.
AuthorsGaurang Patel, Gitanjali Kher, Ambikanandan Misra
JournalJournal of drug targeting (J Drug Target) Vol. 20 Issue 2 Pg. 155-65 (Feb 2012) ISSN: 1029-2330 [Electronic] England
PMID21913877 (Publication Type: Journal Article)
Chemical References
  • Albumins
  • Biomarkers
  • Liposomes
  • Mannosephosphates
  • PPAR gamma
  • Thiazolidinediones
  • rosiglitazone
  • Carbon Tetrachloride
  • Albumins (administration & dosage, chemistry)
  • Animals
  • Biological Availability
  • Biomarkers (metabolism)
  • Carbon Tetrachloride
  • Drug Delivery Systems (methods)
  • Hepatic Stellate Cells (drug effects, metabolism)
  • Humans
  • Injections, Intravenous
  • Liposomes (administration & dosage, chemical synthesis, chemistry)
  • Liver (drug effects, metabolism, pathology)
  • Liver Cirrhosis, Experimental (chemically induced, drug therapy)
  • Male
  • Mannosephosphates (administration & dosage, chemistry)
  • PPAR gamma (agonists)
  • Rats
  • Rats, Sprague-Dawley
  • Thiazolidinediones (administration & dosage, pharmacokinetics, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: